In a recent study posted to the bioRxiv* preprint server, researchers evaluated the use of receptor decoys for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on soluble forms of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback